Targeting the Aging Process
Metformin operates by targeting critical metabolic pathways involved in cellular aging. Its primary mechanism is AMPK activation, a master regulator of energy homeostasis.
By enhancing cellular efficiency, improving glycemic control, and reducing chronic “inflammaging,” metformin addresses multiple biomarkers of aging simultaneously.
Multi-Targeted Physiological Benefits
Incidence Reduction Across Pathologies
Combating Age-Related Diseases
Patients prescribed metformin exhibit lower incidence of severe age-related conditions compared to untreated counterparts.
This protective effect spans cardiovascular decline, certain cancers, and cognitive degradation.
Practical Takeaways
Consult Your Provider
Discuss suitability based on risk factors, especially for prediabetes.
Lifestyle Changes
Combine with balanced diet, regular exercise, and stress management.
Stay Informed
Track new findings on geroprotectors as longevity science evolves.
Combine Approaches
Integrate with intermittent fasting or caloric restriction.
This infographic summarizes current longevity research for informational purposes only. Always consult your healthcare provider regarding treatments and medications.
Based on: Revisiting metformin as a geroprotector (Chen LK).